A detailed history of Pnc Financial Services Group, Inc. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,188 shares of NUVL stock, worth $110,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,188
Previous 1,007 17.97%
Holding current value
$110,163
Previous $76,000 59.21%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$67.44 - $112.17 $12,206 - $20,302
181 Added 17.97%
1,188 $121,000
Q2 2024

Aug 09, 2024

BUY
$62.76 - $81.61 $59,559 - $77,447
949 Added 1636.21%
1,007 $76,000
Q1 2024

May 10, 2024

BUY
$72.35 - $88.99 $2,532 - $3,114
35 Added 152.17%
58 $4,000
Q4 2023

Feb 09, 2024

BUY
$42.42 - $80.28 $975 - $1,846
23 New
23 $1,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.99B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.